Abstract:The effect of intensive insulin therapy on hyperglucagonemia in newly diagnosed type 2 diabetes (T2DM), and its associations with beta-cell function, has not been elucidated. This study assessed the effect of 12 weeks of intensive insulin therapy on hyperglucagonemia in newly diagnosed T2DM and its associations with beta-cell function, with reference to the effects of 12 weeks of oral hypoglycemic agents (OHAs). One hundred eight patients with newly diagnosed T2DM were enrolled from January 2015 to December 2015. The patients were randomly divided to receive, for 12 weeks, either intensive insulin therapy or OHAs. Meal tolerance tests were conducted at baseline before treatment (0 week), at 12 weeks (end of treatment), and 12 months after the initiation of treatment. The levels of glucagon, proinsulin, C-peptide (CP), and blood glucose were measured at timepoints 0, 30, and 120 minutes during the meal tolerance test. Intensive insulin treatment was associated with a decrease in glucagon levels (at 0, 30, and 120 minutes) and proinsulin/CP, and an increase in the insulin-secretion index Delta CP30/Delta G(30) and Delta CP120/Delta G(120), at 12 weeks and 12 months during the follow-up, compared with the corresponding effects of OHAs. Intensive insulin therapy could reduce but failed to normalize glucagon levels at 12 weeks. There were no correlations between the change of percentages in total area under the curve of glucagon and other glycemic parameters (proinsulin/CP; Delta CP30/Delta G(30); or Delta CP120/Delta G(120)). Patients who received intensive insulin therapy were more likely to achieve their target glycemic goal and remission, compared with those who received OHAs. Short-term intensive insulin therapy facilitates the improvement of both beta-cell and alpha-cell function in newly diagnosed T2DM mellitus. Decline of beta-cell secretion and concomitant alpha-cell dysfunction may both be involved in the pathogenesis of T2DM.

Influence of short-term intensive insulin therapy on microalbuminuria in the patients with type 2 siabetes mellitus

Changes of Blood Pressure,blood Glucose and Blood Lipids Levels after Intensive Treatment in Incipient Diabetes II Patients

Effect of Intensive Insulin Therapy on Urinary Intercellular Adhesion Molecule-1 Excretion in Patients with Type 2 Diabetes Mellitus

Intensive insulin therapy reduces the urinary intercellular adhesion molecule-1 excretion in patients with Type 2 diabetes mellitus

Effects ofIntensive Insulin Therapy on Early Diabetic Nephropathy

Effect of intensive insulin therapy on urinary monocyte chemoattractant protein-1 excretion in patients with type 2 diabetes mellitus

Effect of intensive insulin bump on levles of urine albumin in patients with diabetic nephropathy

The effects of short-term insulin intensive treatment on islet B cell function and insulin sensitivity in newly-diagnosed Type 2 Diabetic Patients

Effect of intensive insulin therapy on serum inflammatory factors in newly onset diabetic patients

Effects of Short-Term Intensive Insulin Therapy on PancreaticβCell Functions and Serum Total Bile Acid Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

The analysis of relevant factors in intensive therapy to ameliorate insulin resistance in newly diagnosed type 2 diabetic patients

Effect of short-term intensive insulin pump treatment on related indexes of patients with early type 2 diabetes mellitus

Effects Of Intensive Control Of Blood Glucose And Blood Pressure On Microvascular Complications In Patients With Type Ii Diabetes Mellitus

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.

[Related Factors for Microalbuminuria in Adult Type 1 Diabetes Patients of Short Disease Duration].

Effect of short-term intensive insulin therapy on α-cell function in patients with newly diagnosed type 2 diabetes.

Effect of telmisartan on microalbuminuria in patients with hypertension

Efficacy Observation of the Intensivetherapy of Short-acting Insulin for 32 Patients with Type 2 Diabetes

The Clinical Study on the Relationship of the Levels of Insulin-Like Growth Factor-1 with Urinary Albumin Excretion Rate in Patients with Type 2 Diabetes

Effects of Intensive Blood Glucose Control and Blood Pressure Lowering on Microvascular Complications in Patients with Type 2 Diabetes Mellutis

Impact of short-term insulin pump-intensified therapy on new type 2diabetic patients